Insider Trading History of Ando Dale G

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Ando Dale G since 2012. The trader's CIK number is 1202278. At the time of the last reporting, Ando Dale G was the VP, Therapeutic Dev. & CMO of Sangamo Therapeutics, Inc. (stock ticker symbol SGMO). Also see all insider trading activities at Sangamo Therapeutics, Inc.



Yearly summary of insider trading at Sangamo Therapeutics, Inc (SGMO) by Ando Dale G

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 SGMO 0 $0 90,000 $1,292,325 90,000 $386,325
2014 SGMO 0 $0 135,000 $1,860,645 133,202 $621,035
2013 SGMO 0 $0 165,000 $1,706,445 161,000 $625,443
2012 SGMO 0 $0 101,736 $571,823 75,000 $270,750


Insider trading of Sangamo Therapeutics, Inc (SGMO) by Ando Dale G

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-06-05 SGMO Option Ex 15,000 3.45 51,750
2015-06-05 SGMO Sale 15,000 12.29 184,395
2015-05-05 SGMO Sale 15,000 12.29 184,305
2015-05-05 SGMO Option Ex 15,000 3.45 51,750
2015-04-06 SGMO Option Ex 15,000 3.45 51,750
2015-04-06 SGMO Sale 15,000 14.95 224,175
2015-03-05 SGMO Option Ex 15,000 3.45 51,750
2015-03-05 SGMO Sale 15,000 18.29 274,290
2015-02-05 SGMO Sale 15,000 12.93 193,950
2015-02-05 SGMO Option Ex 15,000 5.13 77,025
2015-01-05 SGMO Sale 15,000 15.41 231,210
2015-01-05 SGMO Option Ex 15,000 6.82 102,300
2014-12-05 SGMO Option Ex 15,000 6.82 102,300
2014-12-05 SGMO Sale 15,000 11.21 168,195
2014-11-05 SGMO Option Ex 15,000 5.46 81,975
2014-11-05 SGMO Sale 15,000 11.35 170,265
2014-10-06 SGMO Sale 15,000 10.72 160,860
2014-10-06 SGMO Option Ex 15,000 4.11 61,650
2014-09-05 SGMO Option Ex 15,000 4.11 61,650
2014-09-05 SGMO Sale 15,000 12.21 183,075
2014-08-05 SGMO Sale 15,000 12.99 194,790
2014-08-05 SGMO Option Ex 13,202 4.11 54,260
2014-05-27 SGMO Sale 15,000 13.57 203,520
2014-05-27 SGMO Option Ex 15,000 4.32 64,800
2014-04-28 SGMO Option Ex 15,000 4.32 64,800
2014-04-28 SGMO Sale 15,000 13.63 204,480
2014-02-26 SGMO Option Ex 15,000 4.32 64,800
2014-02-26 SGMO Sale 15,000 19.72 295,815
2014-01-27 SGMO Sale 15,000 18.64 279,645
2014-01-27 SGMO Option Ex 15,000 4.32 64,800
2013-12-26 SGMO Option Ex 15,000 4.32 64,800
2013-12-26 SGMO Sale 15,000 14.30 214,575
2013-11-26 SGMO Option Ex 15,000 4.08 61,245
2013-11-26 SGMO Sale 15,000 11.82 177,375
2013-10-28 SGMO Option Ex 15,000 4.08 61,245
2013-10-28 SGMO Sale 15,000 10.38 155,775
2013-09-26 SGMO Option Ex 15,000 4.08 61,245
2013-09-26 SGMO Sale 15,000 10.57 158,520
2013-08-26 SGMO Sale 15,000 10.04 150,585
2013-08-26 SGMO Option Ex 13,000 4.08 53,079
2013-07-26 SGMO Option Ex 13,000 4.08 53,079
2013-07-26 SGMO Sale 15,000 10.11 151,575
2013-05-28 SGMO Option Ex 15,000 3.61 54,150
2013-05-28 SGMO Sale 15,000 8.32 124,815
2013-04-26 SGMO Option Ex 15,000 3.61 54,150
2013-04-26 SGMO Sale 15,000 10.72 160,740
2013-03-26 SGMO Option Ex 15,000 3.61 54,150
2013-03-26 SGMO Sale 15,000 9.18 137,730
2013-02-26 SGMO Sale 15,000 8.64 129,600
2013-02-26 SGMO Option Ex 15,000 3.61 54,150
2012-01-28 SGMO Option Ex 15,000 3.61 54,150
2012-01-28 SGMO Sale 15,000 9.68 145,155
2012-12-26 SGMO Option Ex 15,000 3.61 54,150
2012-12-26 SGMO Sale 17,000 5.93 100,861
2012-11-27 SGMO Sale 15,000 5.60 84,000
2012-11-27 SGMO Option Ex 15,000 3.61 54,150
2012-11-26 SGMO Sale 4,736 5.33 25,233
2012-10-26 SGMO Sale 20,000 5.71 114,100
2012-10-26 SGMO Option Ex 15,000 3.61 54,150
2012-10-15 SGMO Sale 5,000 5.68 28,400
2012-09-05 SGMO Option Ex 15,000 3.61 54,150
2012-09-05 SGMO Sale 15,000 5.60 84,000
2012-08-27 SGMO Sale 5,000 5.19 25,970
2012-07-27 SGMO Option Ex 15,000 3.61 54,150
2012-07-26 SGMO Sale 5,000 5.05 25,259
2012-07-27 SGMO Sale 15,000 5.60 84,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ando Dale G (VP, Therapeutic Dev. & CMO of Sangamo Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.